Vascular endothelial growth factor-A (VEGF-A) is known to be a proinflammatory and profibrogenic factor in chronic liver disease [39], and its role in NAFLD has recently received attention in the [40, 41]. The gene discussed is VEGFA; the disease is metabolic dysfunction-associated steatotic liver disease.